 |
114 Diseases |  |
151 Trials |
|
151 Trials |  |
5480 News |  |
| «12...156157158159160161162163164165166167168» |
- || prednisone / Generic mfg., doxycycline / Generic mfg.
New P2/3 trial: Prednisone Versus Doxycycline in the Treatment of Graves' Orbitopathy (clinicaltrials.gov) - Mar 10, 2013
P2/3, N=146, Recruiting, Sponsor: Sun Yat-sen University
- |||| doxycycline / Generic mfg.
Trial completion: Placebo Controlled Efficacy and Safety Study of CD2475/101 40 mg Tablets vs. Placebo and Doxycycline 100 mg Capsules Once Daily in the Treatment of Inflammatory Lesions of Acne Vulgaris (clinicaltrials.gov) - Mar 5, 2013
P2, N=662, Completed, Sponsor: Galderma
Active, not recruiting --> Completed
- | doxycycline / Generic mfg.
New P4 trial: Relationship of Periodontal Disease Treatment and Type 2 Diabetes Mellitus in the Gullah Population (clinicaltrials.gov) - Feb 21, 2013
P4, N=113, Completed, Sponsor: Medical University of South Carolina
- trimethoprim/sulfamethoxazole / Generic mfg., doxycycline / Generic mfg., mupirocin / Generic mfg.
Enrollment change: Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting (clinicaltrials.gov) - Feb 13, 2013
P=N/A, N=15, Completed, Sponsor: Joseph Kim
Active, not recruiting --> Completed N=96 --> 15
- trimethoprim/sulfamethoxazole / Generic mfg., doxycycline / Generic mfg., mupirocin / Generic mfg.
Trial completion: Comprehensive Strategy to Decolonize Methicillin-resistant Staphylococcus Aureus (MRSA) in the Outpatient Setting (clinicaltrials.gov) - Feb 13, 2013
P=N/A, N=15, Completed, Sponsor: Joseph Kim
N=96 --> 15 Recruiting --> Completed
- doxycycline / Generic mfg.
New P3 trial: MI-PCOS: Effect of a Commonly Used Antibiotic, Doxycycline, in Women With Polycystic Ovarian Syndrome (clinicaltrials.gov) - Feb 7, 2013
P3, N=40, Recruiting, Sponsor: University of Rochester
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
New P2 trial: Oral Azithromycin Versus Doxycycline in Posterior Blepharitis (clinicaltrials.gov) - Feb 3, 2013
P2, N=100, Completed, Sponsor: Tehran University of Medical Sciences
- || doxycycline / Generic mfg.
New P2/3 trial: Clinical Study to Evaluate Treatment With ORACEA® for Geographic Atrophy (TOGA) (clinicaltrials.gov) - Jan 31, 2013
P2/3, N=286, Not yet recruiting, Sponsor: Paul Yates, MD, PhD
- | New P2 trial: APRiCCOT: Antibiotics and Hydroxychloroquine in Crohn's (clinicaltrials.gov) - Jan 31, 2013
P2, N=100, Recruiting, Sponsor: Royal Liverpool University Hospital
- doxycycline / Generic mfg.
Enrollment change: A Study of Continuous Oral Contraceptives and Doxycycline (clinicaltrials.gov) - Dec 16, 2012
P=N/A, N=131, Completed, Sponsor: Oregon Health and Science University
Recruiting --> Completed N=200 --> 131
- doxycycline / Generic mfg.
Clinical: Doxycycline for COPD in HIV-Infected Patients (clinicaltrials.gov) - Dec 4, 2012
P=N/A, N=30, Not yet recruiting, Sponsor: Weill Medical College of Cornell University
- || doxycycline / Generic mfg.
New P2/3 trial: Helicobacter Pylori Treatment in Immune Thrombocytopenic Purpura (ITP) Patients (clinicaltrials.gov) - Nov 19, 2012
P2/3, N=100, Completed, Sponsor: Federal University of São Paulo
- doxycycline / Generic mfg.
New P1/2 trial: Efficacy of Subantimicrobial Dose Doxycycline for Moderate to Severe and Active Graves' Orbitopathy (clinicaltrials.gov) - Nov 14, 2012
P1/2, N=14, Completed, Sponsor: Sun Yat-sen University
- Yervoy (ipilimumab) / Ono Pharma, BMS
Enrollment open, Metastases: Doxycycline, Temozolomide and Ipilimumab in Melanoma (clinicaltrials.gov) - Nov 5, 2012
P1/2, N=58, Recruiting, Sponsor: M.D. Anderson Cancer Center
N=200 --> 131 Not yet recruiting --> Recruiting
- Trial initiation date: Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (clinicaltrials.gov) - Oct 7, 2012
P2, N=40, Recruiting, Sponsor: Michael Boyle
Not yet recruiting --> Recruiting Initiation date: Jul 2012 --> Oct 2012
- Enrollment open: Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (clinicaltrials.gov) - Oct 7, 2012
P2, N=40, Recruiting, Sponsor: Michael Boyle
Initiation date: Jul 2012 --> Oct 2012 Not yet recruiting --> Recruiting
- doxycycline / Generic mfg.
Enrollment change: Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy (clinicaltrials.gov) - Oct 3, 2012
P2, N=33, Completed, Sponsor: Thomas W. Gardner
Not yet recruiting --> Recruiting N=60 --> 33
- doxycycline / Generic mfg.
Enrollment change: POC1: Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy (clinicaltrials.gov) - Oct 3, 2012
P2, N=28, Completed, Sponsor: Thomas W. Gardner
N=60 --> 33 N=60 --> 28
- doxycycline / Generic mfg.
Trial completion: Evaluation of Effect of Doxycycline Verses Placebo on Retinal Function and Diabetic Retinopathy (clinicaltrials.gov) - Oct 3, 2012
P2, N=33, Completed, Sponsor: Thomas W. Gardner
N=60 --> 28 Active, not recruiting --> Completed
- doxycycline / Generic mfg.
Trial completion: POC1: Evaluation of Doxycycline Verses Placebo for the Treatment of Severe Nonproliferative or Mild or Moderate Proliferative Diabetic Retinopathy (clinicaltrials.gov) - Oct 3, 2012
P2, N=28, Completed, Sponsor: Thomas W. Gardner
Active, not recruiting --> Completed Active, not recruiting --> Completed
- ciprofloxacin oral / Generic mfg., doxycycline / Generic mfg.
Enrollment open, Head-to-Head: A Clinical Trial to Evaluate the Safety and Efficacy of Ciprofloxacin in the Treatment of Plague in Humans (clinicaltrials.gov) - Sep 9, 2012
P2, N=200, Recruiting, Sponsor: Centers for Disease Control and Prevention
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- | doxycycline / Generic mfg.
New P2 trial: Safety and Effect of Doxycycline in Patients With Amyloidosis (clinicaltrials.gov) - Aug 30, 2012
P2, N=60, Recruiting, Sponsor: Boston University
- ||||| Vectibix (panitumumab) / Amgen, Takeda
New P2 trial, HEOR: Comparison of Two Preemptive Treatment Strategies of Panitumumab Mediated Skin Toxicity and Assessment of QoL in Patient With Ras-wt Colorectal Cancer (clinicaltrials.gov) - Aug 16, 2012
P2, N=74, Recruiting, Sponsor: AIO-Studien-gGmbH
- | Tetralysal (lymecycline) / Galderma
New P4 trial: Time to Eradication of Mycoplasma Genitalium and Chlamydia Trachomatis After Treatment Commenced (clinicaltrials.gov) - Aug 8, 2012
P4, N=160, Recruiting, Sponsor: Ostergotland County Council, Sweden
- doxycycline / Generic mfg.
Biomarker: The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine (clinicaltrials.gov) - Jul 29, 2012
P=N/A, N=40, Recruiting, Sponsor: The Cleveland Clinic
- ||| Vizimpro (dacomitinib) / Pfizer
Enrollment change, Adverse events, Patient reported outcomes, Metastases: ARCHER 1042: Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO (clinicaltrials.gov) - Jul 22, 2012
P2, N=184, Recruiting, Sponsor: Pfizer
Not yet recruiting --> Recruiting N=240 --> 184
- doxycycline / Generic mfg.
Enrollment change: Duration of Antibiotic Treatment of Erythema Migrans (clinicaltrials.gov) - Jul 17, 2012
P=N/A, N=306, Completed, Sponsor: University Medical Centre Ljubljana
N=240 --> 184 N=405 --> 306
- | ceftriaxone / Generic mfg., doxycycline / Generic mfg.
New P4 trial: Study of Lyme Neuroborreliosis (clinicaltrials.gov) - Jul 5, 2012
P4, N=150, Not yet recruiting, Sponsor: Turku University Hospital
- | cephalexin / Generic mfg., trimethoprim/sulfamethoxazole / Generic mfg., doxycycline / Generic mfg.
New P2 trial: Effects of Treatments on Atopic Dermatitis (clinicaltrials.gov) - Jun 27, 2012
P2, N=105, Recruiting, Sponsor: National Cancer Institute (NCI)
- ||| doxycycline / Generic mfg.
Enrollment closed: Evaluation of Relapse, Efficacy and Safety of Long-term Treatment With Oracea® vs Placebo (clinicaltrials.gov) - Jun 24, 2012
P4, N=200, Active, not recruiting, Sponsor: Galderma Laboratories, L.P.
N=405 --> 306 Recruiting --> Active, not recruiting
- doxycycline / Generic mfg.
Enrollment closed: Doxycycline In Lymphangioleiomyomatosis (LAM) (clinicaltrials.gov) - Jun 13, 2012
P4, N=40, Active, not recruiting, Sponsor: University of Nottingham
Recruiting --> Active, not recruiting Recruiting --> Active, not recruiting
- tetracycline / Generic mfg.
Enrollment change: IELSG27: A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae (clinicaltrials.gov) - May 23, 2012
P2, N=54, Completed, Sponsor: International Extranodal Lymphoma Study Group (IELSG)
Recruiting --> Active, not recruiting N=100 --> 54
- tetracycline / Generic mfg.
Trial completion: IELSG27: A Clinico-Pathological Study to Investigate the Possible Infective Causes of Non-Hodgkin Lymphoma of the Ocular Adnexae (clinicaltrials.gov) - May 23, 2012
P2, N=54, Completed, Sponsor: International Extranodal Lymphoma Study Group (IELSG)
N=100 --> 54 Active, not recruiting --> Completed
- doxycycline / Generic mfg.
New P3 trial: Comparison Between aPDT and Systemic Doxycycline on Non-surgical Periodontal Therapy in Type 2 Diabetics (clinicaltrials.gov) - May 8, 2012
P3, N=40, Recruiting, Sponsor: University of Sao Paulo
- New P2 trial: Persistent Methicillin Resistant Staphylococcus Aureus Eradication Protocol (PMEP) (clinicaltrials.gov) - May 7, 2012
P2, N=40, Recruiting, Sponsor: Michael Boyle
- | Yervoy (ipilimumab) / Ono Pharma, BMS
New P1/2 trial, Metastases: Doxycycline, Temozolomide and Ipilimumab in Melanoma (clinicaltrials.gov) - Apr 30, 2012
P1/2, N=58, Recruiting, Sponsor: M.D. Anderson Cancer Center
- doxycycline / Generic mfg.
Trial withdrawal: Doxycycline Outcomes in Lupus Erythematosus (clinicaltrials.gov) - Mar 28, 2012
P4, N=0, Withdrawn, Sponsor: Johns Hopkins University
Active, not recruiting --> Completed Not yet recruiting --> Withdrawn
- doxycycline / Generic mfg.
Enrollment change: Doxycycline Outcomes in Lupus Erythematosus (clinicaltrials.gov) - Mar 28, 2012
P4, N=0, Withdrawn, Sponsor: Johns Hopkins University
Not yet recruiting --> Withdrawn N=60 --> 0
- | doxycycline / Generic mfg., azithromycin / Generic mfg.
Enrollment open: Development of an Optimal Antibiotic Regime for Long-term Therapy in Stable Chronic Obstructive Pulmonary Disease (COPD) (clinicaltrials.gov) - Mar 13, 2012
P3, N=200, Recruiting, Sponsor: University College, London
N=60 --> 0 Not yet recruiting --> Recruiting
- doxycycline / Generic mfg., tetracycline / Generic mfg.
Trial completion: TIPTOP: Tetracycline (Doxycycline) and Post Myocardial Infarction Remodeling (clinicaltrials.gov) - Feb 15, 2012
P2, N=110, Completed, Sponsor: Careggi Hospital
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- doxycycline / Generic mfg.
Trial completion: A Study of Continuous Oral Contraceptives and Doxycycline (clinicaltrials.gov) - Feb 8, 2012
P=N/A, N=131, Completed, Sponsor: Oregon Health and Science University
Active, not recruiting --> Completed Active, not recruiting --> Completed
- |||| Vizimpro (dacomitinib) / Pfizer
Enrollment open, Adverse events, Patient reported outcomes, Metastases: ARCHER 1042: Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO (clinicaltrials.gov) - Feb 4, 2012
P2, N=184, Recruiting, Sponsor: Pfizer
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| doxycycline / Generic mfg.
New P2 trial: A Clinical Trial of YH14642 in Patients With Chronic Periodontal Disease (clinicaltrials.gov) - Dec 22, 2011
P2, N=162, Active, not recruiting, Sponsor: Yuhan Corporation
- | doxycycline / Generic mfg.
Trial completion: DOX-DMPA: Doxycycline in Treatment of Bleeding With Depot Medroxyprogesterone Acetate (DMPA) (clinicaltrials.gov) - Nov 24, 2011
P3, N=68, Completed, Sponsor: Omar Mamdouh Shaaban
Not yet recruiting --> Recruiting Active, not recruiting --> Completed
- |||||||||| doxycycline / Generic mfg., adapalene/benzoyl peroxide / Generic mfg., isotretinoin / Generic mfg.
New P3 trial: Efficacy & Safety Comparison of Epiduo With Doxycycline Versus Vehicle With Isotretinoin in the Treatment of Severe Acne (clinicaltrials.gov) - Nov 16, 2011
P3, N=266, Completed, Sponsor: Galderma
- ||||| Vizimpro (dacomitinib) / Pfizer
New P2 trial, Adverse events, Patient reported outcomes, Metastases: ARCHER 1042: Study Of Dacomitinib (PF-00299804) In Advanced NSCLC Patients (Post Chemo Or Select First Line) To Evaluate Prophylactic Intervention On Derm And GI AEs And PRO (clinicaltrials.gov) - Nov 3, 2011
P2, N=184, Recruiting, Sponsor: Pfizer
- doxycycline / Generic mfg., voriconazole / Generic mfg.
Trial completion: A Pilot of Pediatric/Adult Study of Gene Expression Profiling and Clinical Characterization of Phototoxicity (clinicaltrials.gov) - Sep 28, 2011
P=N/A, N=62, Completed, Sponsor: National Cancer Institute (NCI)
Active, not recruiting --> Completed Recruiting --> Completed
- Clinical: Randomized Controlled Trial of Standard Versus Systemic Decolonization Therapy for the Eradication of Methicillin-resistant Staphylococcus Aureus (MRSA) Colonization (clinicaltrials.gov) - Sep 20, 2011
P=N/A, N=200, Recruiting, Sponsor: Horizon Health Network
- ||| Clinical: Risk of Acute Liver Injury in Users of Antimicrobials (clinicaltrials.gov) - Sep 12, 2011
P=N/A, N=1299056, Completed, Sponsor: Bayer
- doxycycline / Generic mfg.
Trial termination: GTRDOXY: Effect of Postsurgical Systemic Doxycycline After Regenerative Periodontal Therapy (clinicaltrials.gov) - Sep 5, 2011
P4, N=61, Terminated, Sponsor: Peter Eickholz
Recruiting --> Completed Active, not recruiting --> Terminated; shelf life of investigational drug ran out before 90 patients could be included